Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
HIF-1 induces cell cycle arrest by functionally counteracting Myc
Minori Koshiji1,
Yukio Kageyama1,
Erin A Pete1,
Izumi Horikawa2,
J Carl Barrett2, and
L Eric Huang1,+
1 Laboratory of Human Carcinogenesis, NCI, National Institutes of Health, Bethesda, MD, USA 2 Laboratory of Biosystems and Cancer, NCI, National Institutes of Health, Bethesda, MD, USA
Abstract:
Hypoxia induces angiogenesis and glycolysis for cell growthand survival, and also leads to growth arrest and apoptosis.HIF-1, a basic helixloophelix PAS transcriptionfactor, acts as a master regulator of oxygen homeostasis byupregulating various genes under low oxygen tension. Althoughgenetic studies have indicated the requirement of HIF-1 forhypoxia-induced growth arrest and activation of p21cip1, a keycyclin-dependent kinase inhibitor controlling cell cycle checkpoint,the mechanism underlying p21cip1 activation has been elusive.Here we demonstrate that HIF-1, even in the absence of hypoxicsignal, induces cell cycle arrest by functionally counteractingMyc, thereby derepressing p21cip1. The HIF-1 antagonism is mediatedby displacing Myc binding from p21cip1 promoter. Neither HIF-1transcriptional activity nor its DNA binding is essential forcell cycle arrest, indicating a divergent role for HIF-1. Inkeeping with its antagonism of Myc, HIF-1 also downregulatesMyc-activated genes such as hTERT and BRCA1. Hence, we proposethat Myc is an integral part of a novel HIF-1 pathway, whichregulates a distinct group of Myc target genes in response tohypoxia.